113 related articles for article (PubMed ID: 8216563)
21. Evaluation of the potency and safety of inactivated Japanese encephalitis vaccine in US inhabitants.
Poland JD; Cropp CB; Craven RB; Monath TP
J Infect Dis; 1990 May; 161(5):878-82. PubMed ID: 2324539
[TBL] [Abstract][Full Text] [Related]
22. Needle-free jet injection of a mixture of Japanese encephalitis DNA and protein vaccines: a strategy to effectively enhance immunogenicity of the DNA vaccine in a murine model.
Imoto J; Konishi E
Viral Immunol; 2005; 18(1):205-12. PubMed ID: 15802965
[TBL] [Abstract][Full Text] [Related]
23. Immunizing children aged 9 to 15 months with live attenuated SA14-14-2 Japanese encephalitis vaccine in Thailand.
Chotpitayasunondh T; Sohn YM; Yoksan S; Min J; Ohrr H
J Med Assoc Thai; 2011 Aug; 94 Suppl 3():S195-203. PubMed ID: 22043776
[TBL] [Abstract][Full Text] [Related]
24. Superior immunogenicity of a freeze-dried, cell culture-derived Japanese encephalitis vaccine (inactivated).
Kikukawa A; Gomi Y; Akechi M; Onishi T; Manabe S; Namazue J; Fuke I; Ishikawa T; Okuno Y; Ueda S
Vaccine; 2012 Mar; 30(13):2329-35. PubMed ID: 22306856
[TBL] [Abstract][Full Text] [Related]
25. [Analysis on the immuno-effects of two different Japanese encephalitis virus vaccines].
Guo W; Li L; Wu Z
Zhonghua Liu Xing Bing Xue Za Zhi; 1998 Apr; 19(2):97-9. PubMed ID: 10322719
[TBL] [Abstract][Full Text] [Related]
26. Effect of genomic variation in the challenge virus on the neutralization titres of recipients of inactivated JE vaccines--report of a collaborative study on PRNT50 assays for Japanese encephalitis virus (JE) antibodies.
Ferguson M; Johnes S; Li L; Heath A; Barrett A
Biologicals; 2008 Mar; 36(2):111-6. PubMed ID: 17892945
[TBL] [Abstract][Full Text] [Related]
27. Antibody Persistence up to 3 Years After Primary Immunization With Inactivated Japanese Encephalitis Vaccine IXIARO in Philippine Children and Effect of a Booster Dose.
Kadlecek V; Borja-Tabora CF; Eder-Lingelbach S; Gatchalian S; Kiermayr S; Sablan B; Kundi M; Taucher C; Dubischar KL
Pediatr Infect Dis J; 2018 Sep; 37(9):e233-e240. PubMed ID: 29912844
[TBL] [Abstract][Full Text] [Related]
28. T-cell activation and induction of antibodies and memory T cells by immunization with inactivated Japanese encephalitis vaccine.
Aihara H; Takasaki T; Toyosaki-Maeda T; Suzuki R; Okuno Y; Kurane I
Viral Immunol; 2000; 13(2):179-86. PubMed ID: 10892998
[TBL] [Abstract][Full Text] [Related]
29. The efficacy of mouse-brain inactivated Nakayama strain Japanese encephalitis vaccine--results from 30 years experience in Taiwan.
Yang SE; Pan MJ; Tseng HF; Liau MY
Vaccine; 2006 Mar; 24(14):2669-73. PubMed ID: 16314007
[TBL] [Abstract][Full Text] [Related]
30. The efficacy of Japanese encephalitis vaccine in Henan, China: a case-control study.
Luo D; Yin H; Xili L; Song J; Wang Z
Southeast Asian J Trop Med Public Health; 1994 Dec; 25(4):643-6. PubMed ID: 7667706
[TBL] [Abstract][Full Text] [Related]
31. A field study on Nakayama and Beijing strains of Japanese encephalitis vaccines.
Nimmannitya S; Hutamai S; Kalayanarooj S; Rojanasuphot S
Southeast Asian J Trop Med Public Health; 1995 Dec; 26(4):689-93. PubMed ID: 9139377
[TBL] [Abstract][Full Text] [Related]
32. Needle-free jet injection of small doses of Japanese encephalitis DNA and inactivated vaccine mixture induces neutralizing antibodies in miniature pigs and protects against fetal death and mummification in pregnant sows.
Imoto J; Ishikawa T; Yamanaka A; Konishi M; Murakami K; Shibahara T; Kubo M; Lim CK; Hamano M; Takasaki T; Kurane I; Udagawa H; Mukuta Y; Konishi E
Vaccine; 2010 Oct; 28(46):7373-80. PubMed ID: 20851083
[TBL] [Abstract][Full Text] [Related]
33. Protection against Japanese encephalitis by inactivated vaccines.
Hoke CH; Nisalak A; Sangawhipa N; Jatanasen S; Laorakapongse T; Innis BL; Kotchasenee S; Gingrich JB; Latendresse J; Fukai K
N Engl J Med; 1988 Sep; 319(10):608-14. PubMed ID: 2842677
[TBL] [Abstract][Full Text] [Related]
34. Immune status of volunteers one year after administration of Japanese encephalitis vaccine produced in India.
Saxena SN; Bhau LN; Singh G; Gowal D; Sood YK; Misra CN; Das BK
Indian J Med Res; 1989 Nov; 89():362-7. PubMed ID: 2559892
[TBL] [Abstract][Full Text] [Related]
35. Neutralizing antibody responses to Japanese encephalitis vaccine in children.
Juang RF; Fukai K
Zhonghua Min Guo Wei Sheng Wu Ji Mian Yi Xue Za Zhi; 1983 Sep; 16(3):190-7. PubMed ID: 6680096
[TBL] [Abstract][Full Text] [Related]
36. Neutralizing antibody responses to Japanese encephalitis vaccine in children.
Juang RF; Okuno Y; Fukunaga T; Tadano M; Fukai K; Baba K; Tsuda N; Yamada A; Yabuuchi H
Biken J; 1983 Mar; 26(1):25-34. PubMed ID: 6626137
[TBL] [Abstract][Full Text] [Related]
37. Immunogenicity of one dose of Vero cell culture-derived Japanese encephalitis (JE) vaccine in adults previously vaccinated with mouse brain-derived JE vaccine.
Woolpert T; Staples JE; Faix DJ; Nett RJ; Kosoy OI; Biggerstaff BJ; Johnson BW; Sracic M; Fischer M
Vaccine; 2012 Apr; 30(20):3090-6. PubMed ID: 22406277
[TBL] [Abstract][Full Text] [Related]
38. [Effect of cytoxan on immune response of Japanese encephalitis virus killed and live vaccines].
Fang QA; Chen BQ
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1989 Oct; 11(5):317-21. PubMed ID: 2561510
[TBL] [Abstract][Full Text] [Related]
39. Characterization of immune responses induced by inactivated, live attenuated and DNA vaccines against Japanese encephalitis virus in mice.
Li J; Chen H; Wu N; Fan D; Liang G; Gao N; An J
Vaccine; 2013 Aug; 31(38):4136-42. PubMed ID: 23845821
[TBL] [Abstract][Full Text] [Related]
40. Safety and immunogenicity of concomitant vaccination with the cell-culture based Japanese Encephalitis vaccine IC51 and the hepatitis A vaccine HAVRIX1440 in healthy subjects: A single-blind, randomized, controlled Phase 3 study.
Kaltenböck A; Dubischar-Kastner K; Eder G; Jilg W; Klade C; Kollaritsch H; Paulke-Korinek M; von Sonnenburg F; Spruth M; Tauber E; Wiedermann U; Schuller E
Vaccine; 2009 Jul; 27(33):4483-9. PubMed ID: 19486955
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
